tovorafenib
day one biopharmaceutical
['tovorafenib', 'firefly-1', '$dawn']
jonesresearch raised pt $dawn $45 was $40/buy co's inv call reit'd their robust efficacy data presented at an oral session at #asco23. jones expects a high probability of approval based on firefly-1 results and tovorafenib's safety profile. $eras 